Measurement of Cut-off Perfusion Index Value in Infraclavicular Blocks

NCT ID: NCT05234541

Last Updated: 2022-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-01

Study Completion Date

2022-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the value of the cut-off perfusion index showing that the block is successful in infraclavicular blocks performed under ultrasound guidance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In upper extremity procedures, ultrasound (US) guided infraclavicular block is a frequently used approach. Today, the frequency of studies on the perfusion index (PI), which can be used as a criterion in the evaluation of block success, is increasing. The aim of this study is to evaluate the success and effectiveness of infraclavicular approach block with perfusion index using ROC (Receiver Operating Characteristic) curves.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Extremity Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA 1-2 PATIENTS
* PATIENTS BETWEEN 18-65 YEARS
* PATIENTS WITH INFRACLAVICULAR BLOCK

Exclusion Criteria

* ASA3-4 PATIENTS
* PATIENTS UNDER THE AGE OF 18, PATIENTS OVER 65
* PATIENTS WHO DO NOT WANT TO BE INCLUDED IN THE STUDY
* PATIENTS WITH CONTRAINDICATION TO INFRACLAVICULAR BLOCK
* PATIENTS WITHOUT COOPERATION
* PATIENTS WITH DIABETES MELLITUS
* THOSE WHO HAVE PERIPHERAL ARTERY DISEASE
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Adiyaman University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

MEHMET DURAN

assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adıyaman University Recruitment

Adıyaman, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISEYHANLI

Identifier Type: OTHER

Identifier Source: secondary_id

2020/6-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preoperative Evaluation of Airway
NCT03597880 COMPLETED NA